147 related articles for article (PubMed ID: 28957425)
1. A tissue-specific promoter derived from a SINE retrotransposon drives biallelic expression of PLAGL1 in human lymphocytes.
Smith CEL; Alexandraki A; Cordery SF; Parmar R; Bonthron DT; Valleley EMA
PLoS One; 2017; 12(9):e0185678. PubMed ID: 28957425
[TBL] [Abstract][Full Text] [Related]
2. Tissue-specific imprinting of the ZAC/PLAGL1 tumour suppressor gene results from variable utilization of monoallelic and biallelic promoters.
Valleley EM; Cordery SF; Bonthron DT
Hum Mol Genet; 2007 Apr; 16(8):972-81. PubMed ID: 17341487
[TBL] [Abstract][Full Text] [Related]
3. Loss of expression of ZAC/PLAGL1 in diffuse large B-cell lymphoma is independent of promoter hypermethylation.
Valleley EM; Cordery SF; Carr IM; MacLennan KA; Bonthron DT
Genes Chromosomes Cancer; 2010 May; 49(5):480-6. PubMed ID: 20175198
[TBL] [Abstract][Full Text] [Related]
4. The human HYMAI/PLAGL1 differentially methylated region acts as an imprint control region in mice.
Arima T; Yamasaki K; John RM; Kato K; Sakumi K; Nakabeppu Y; Wake N; Kono T
Genomics; 2006 Nov; 88(5):650-8. PubMed ID: 16928428
[TBL] [Abstract][Full Text] [Related]
5. The cell cycle control gene ZAC/PLAGL1 is imprinted--a strong candidate gene for transient neonatal diabetes.
Kamiya M; Judson H; Okazaki Y; Kusakabe M; Muramatsu M; Takada S; Takagi N; Arima T; Wake N; Kamimura K; Satomura K; Hermann R; Bonthron DT; Hayashizaki Y
Hum Mol Genet; 2000 Feb; 9(3):453-60. PubMed ID: 10655556
[TBL] [Abstract][Full Text] [Related]
6. LOT1 (PLAGL1/ZAC1), the candidate tumor suppressor gene at chromosome 6q24-25, is epigenetically regulated in cancer.
Abdollahi A; Pisarcik D; Roberts D; Weinstein J; Cairns P; Hamilton TC
J Biol Chem; 2003 Feb; 278(8):6041-9. PubMed ID: 12473647
[TBL] [Abstract][Full Text] [Related]
7. Imprinting at the PLAGL1 domain is contained within a 70-kb CTCF/cohesin-mediated non-allelic chromatin loop.
Iglesias-Platas I; Court F; Camprubi C; Sparago A; Guillaumet-Adkins A; Martin-Trujillo A; Riccio A; Moore GE; Monk D
Nucleic Acids Res; 2013 Feb; 41(4):2171-9. PubMed ID: 23295672
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of PLAGL1-specific CpG site methylation in soft-tissue sarcomas.
Peille AL; Brouste V; Kauffmann A; Lagarde P; Le Morvan V; Coindre JM; Chibon F; Bresson-Bepoldin L
PLoS One; 2013; 8(11):e80741. PubMed ID: 24260468
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the methylation-sensitive promoter of the imprinted ZAC gene supports its role in transient neonatal diabetes mellitus.
Varrault A; Bilanges B; Mackay DJ; Basyuk E; Ahr B; Fernandez C; Robinson DO; Bockaert J; Journot L
J Biol Chem; 2001 Jun; 276(22):18653-6. PubMed ID: 11297535
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of the imprinted transcription factor PLAGL1 deregulates a network of genes in the human IUGR placenta.
Iglesias-Platas I; Martin-Trujillo A; Petazzi P; Guillaumet-Adkins A; Esteller M; Monk D
Hum Mol Genet; 2014 Dec; 23(23):6275-85. PubMed ID: 24993786
[TBL] [Abstract][Full Text] [Related]
11. Genomic Imprinting at the Porcine
Ahn J; Hwang IS; Park MR; Hwang S; Lee K
Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33918057
[TBL] [Abstract][Full Text] [Related]
12. Both gene deletion and promoter hyper-methylation contribute to the down-regulation of ZAC/PLAGL1 gene in gastric adenocarcinomas: a case control study.
Li Z; Ding Y; Zhu Y; Yin M; Le X; Wang L; Yang Y; Zhang Q
Clin Res Hepatol Gastroenterol; 2014 Dec; 38(6):744-50. PubMed ID: 25091631
[TBL] [Abstract][Full Text] [Related]
13. PLAGL1 epimutation and bladder exstrophy: Coincidence or concurrent etiology?
Kolarova J; Bens S; Ammerpohl O; Hilger AC; Zhang R; Reutter H; Siebert R
Birth Defects Res A Clin Mol Teratol; 2016 Aug; 106(8):724-8. PubMed ID: 27223093
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the role of common genetic variation in the transient neonatal diabetes mellitus (TNDM) region in type 2 diabetes: a comparative genomic and tagging single nucleotide polymorphism approach.
Gloyn AL; Mackay DJ; Weedon MN; McCarthy MI; Walker M; Hitman G; Knight BA; Owen KR; Hattersley AT; Frayling TM
Diabetes; 2006 Aug; 55(8):2272-6. PubMed ID: 16873690
[TBL] [Abstract][Full Text] [Related]
15. Tumor suppressor gene ZAC/PLAGL1: altered expression and loss of the nonimprinted allele in pheochromocytomas.
Jarmalaite S; Laurinaviciene A; Tverkuviene J; Kalinauskaite N; Petroska D; Böhling T; Husgafvel-Pursiainen K
Cancer Genet; 2011 Jul; 204(7):398-404. PubMed ID: 21872827
[TBL] [Abstract][Full Text] [Related]
16. Relaxation of imprinted expression of ZAC and HYMAI in a patient with transient neonatal diabetes mellitus.
Mackay DJ; Coupe AM; Shield JP; Storr JN; Temple IK; Robinson DO
Hum Genet; 2002 Feb; 110(2):139-44. PubMed ID: 11935319
[TBL] [Abstract][Full Text] [Related]
17. PLAGL1 (ZAC1/LOT1) Expression in Clear Cell Renal Cell Carcinoma: Correlations with Disease Progression and Unfavorable Prognosis.
Godlewski J; Krazinski BE; Kowalczyk AE; Kiewisz J; Kiezun J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Maslowski Z; Kmiec Z
Anticancer Res; 2016 Feb; 36(2):617-24. PubMed ID: 26851016
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide mapping of infection-induced SINE RNAs reveals a role in selective mRNA export.
Karijolich J; Zhao Y; Alla R; Glaunsinger B
Nucleic Acids Res; 2017 Jun; 45(10):6194-6208. PubMed ID: 28334904
[TBL] [Abstract][Full Text] [Related]
19. LOT1 (ZAC1/PLAGL1) and its family members: mechanisms and functions.
Abdollahi A
J Cell Physiol; 2007 Jan; 210(1):16-25. PubMed ID: 17063461
[TBL] [Abstract][Full Text] [Related]
20. Characterization of novel paternal ncRNAs at the Plagl1 locus, including Hymai, predicted to interact with regulators of active chromatin.
Iglesias-Platas I; Martin-Trujillo A; Cirillo D; Court F; Guillaumet-Adkins A; Camprubi C; Bourc'his D; Hata K; Feil R; Tartaglia G; Arnaud P; Monk D
PLoS One; 2012; 7(6):e38907. PubMed ID: 22723905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
